Open AccessAssociation Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Author(s) -
ChunYing Wu,
YiJu Chen,
Hsiu J. Ho,
YaoChun Hsu,
Ken N. Kuo,
MingShiang Wu,
JawTown Lin
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/2012.jama.11975
Subject(s) - medicine , hepatocellular carcinoma , cohort , hazard ratio , nucleoside analogue , gastroenterology , proportional hazards model , cirrhosis , hepatitis b virus , cohort study , retrospective cohort study , surgery , nucleoside , confidence interval , virus , immunology , chemistry , stereochemistry
Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom